Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels

Sharon Moe, Danxia Duan, Brian P. Doehle, Kalisha D. O'Neill, Xuening (Neal) Chen

Research output: Contribution to journalArticle

264 Citations (Scopus)

Abstract

Background. Bone matrix proteins are expressed in calcified arteries from dialysis patients, suggesting that vascular smooth muscle cells (VSMCs) may transform to osteoblast-like cells. One of the key transcriptional regulators of osteoblast differentiation is Cbfa1. Thus, we hypothesized that this may be a key factor in arterial calcification. Methods. To test this hypothesis, we examined sections of the inferior epigastric artery from uremic patients for the presence of Cbfa1 and type I collagen and osteopontin by in situ hybridization and immunostaining. We also examined the effect of pooled uremic sera from dialysis patients on the expression of Cbfa1 by reverse transcription-polymerase chain reaction (RT-PCR) in bovine VSMCs in vitro. Results. Cbfa1 and osteopontin were expressed in both the media and the intima in vessels that were calcified, but there was only minimal staining in non-calcified vessels. In vitro studies demonstrated that pooled uremic serum, compared to pooled control human serum induced the expression of Cbfa1 by RT-PCR in bovine VSMCs in a time-dependent, nonphosphorus-mediated mechanism. Conclusion. These results support that Cbfa1 is a key regulatory factor in the vascular calcification observed in dialysis patients and is up-regulated in response to many uremic toxins.

Original languageEnglish
Pages (from-to)1003-1011
Number of pages9
JournalKidney International
Volume63
Issue number3
DOIs
StatePublished - Mar 1 2003

Fingerprint

Uremia
Osteoblasts
Blood Vessels
Vascular Smooth Muscle
Smooth Muscle Myocytes
Dialysis
Osteopontin
Reverse Transcription
Serum
Epigastric Arteries
Vascular Calcification
Polymerase Chain Reaction
Bone Matrix
Collagen Type I
In Situ Hybridization
Arteries
Staining and Labeling
Proteins
In Vitro Techniques

Keywords

  • Cbfa1
  • Dialysis
  • Osteopontin
  • Type 1 collagen
  • Vascular calcification

ASJC Scopus subject areas

  • Nephrology

Cite this

Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. / Moe, Sharon; Duan, Danxia; Doehle, Brian P.; O'Neill, Kalisha D.; Chen, Xuening (Neal).

In: Kidney International, Vol. 63, No. 3, 01.03.2003, p. 1003-1011.

Research output: Contribution to journalArticle

Moe, Sharon ; Duan, Danxia ; Doehle, Brian P. ; O'Neill, Kalisha D. ; Chen, Xuening (Neal). / Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. In: Kidney International. 2003 ; Vol. 63, No. 3. pp. 1003-1011.
@article{fbaafc5b46394a94901302bba1254750,
title = "Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels",
abstract = "Background. Bone matrix proteins are expressed in calcified arteries from dialysis patients, suggesting that vascular smooth muscle cells (VSMCs) may transform to osteoblast-like cells. One of the key transcriptional regulators of osteoblast differentiation is Cbfa1. Thus, we hypothesized that this may be a key factor in arterial calcification. Methods. To test this hypothesis, we examined sections of the inferior epigastric artery from uremic patients for the presence of Cbfa1 and type I collagen and osteopontin by in situ hybridization and immunostaining. We also examined the effect of pooled uremic sera from dialysis patients on the expression of Cbfa1 by reverse transcription-polymerase chain reaction (RT-PCR) in bovine VSMCs in vitro. Results. Cbfa1 and osteopontin were expressed in both the media and the intima in vessels that were calcified, but there was only minimal staining in non-calcified vessels. In vitro studies demonstrated that pooled uremic serum, compared to pooled control human serum induced the expression of Cbfa1 by RT-PCR in bovine VSMCs in a time-dependent, nonphosphorus-mediated mechanism. Conclusion. These results support that Cbfa1 is a key regulatory factor in the vascular calcification observed in dialysis patients and is up-regulated in response to many uremic toxins.",
keywords = "Cbfa1, Dialysis, Osteopontin, Type 1 collagen, Vascular calcification",
author = "Sharon Moe and Danxia Duan and Doehle, {Brian P.} and O'Neill, {Kalisha D.} and Chen, {Xuening (Neal)}",
year = "2003",
month = "3",
day = "1",
doi = "10.1046/j.1523-1755.2003.00820.x",
language = "English",
volume = "63",
pages = "1003--1011",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels

AU - Moe, Sharon

AU - Duan, Danxia

AU - Doehle, Brian P.

AU - O'Neill, Kalisha D.

AU - Chen, Xuening (Neal)

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Background. Bone matrix proteins are expressed in calcified arteries from dialysis patients, suggesting that vascular smooth muscle cells (VSMCs) may transform to osteoblast-like cells. One of the key transcriptional regulators of osteoblast differentiation is Cbfa1. Thus, we hypothesized that this may be a key factor in arterial calcification. Methods. To test this hypothesis, we examined sections of the inferior epigastric artery from uremic patients for the presence of Cbfa1 and type I collagen and osteopontin by in situ hybridization and immunostaining. We also examined the effect of pooled uremic sera from dialysis patients on the expression of Cbfa1 by reverse transcription-polymerase chain reaction (RT-PCR) in bovine VSMCs in vitro. Results. Cbfa1 and osteopontin were expressed in both the media and the intima in vessels that were calcified, but there was only minimal staining in non-calcified vessels. In vitro studies demonstrated that pooled uremic serum, compared to pooled control human serum induced the expression of Cbfa1 by RT-PCR in bovine VSMCs in a time-dependent, nonphosphorus-mediated mechanism. Conclusion. These results support that Cbfa1 is a key regulatory factor in the vascular calcification observed in dialysis patients and is up-regulated in response to many uremic toxins.

AB - Background. Bone matrix proteins are expressed in calcified arteries from dialysis patients, suggesting that vascular smooth muscle cells (VSMCs) may transform to osteoblast-like cells. One of the key transcriptional regulators of osteoblast differentiation is Cbfa1. Thus, we hypothesized that this may be a key factor in arterial calcification. Methods. To test this hypothesis, we examined sections of the inferior epigastric artery from uremic patients for the presence of Cbfa1 and type I collagen and osteopontin by in situ hybridization and immunostaining. We also examined the effect of pooled uremic sera from dialysis patients on the expression of Cbfa1 by reverse transcription-polymerase chain reaction (RT-PCR) in bovine VSMCs in vitro. Results. Cbfa1 and osteopontin were expressed in both the media and the intima in vessels that were calcified, but there was only minimal staining in non-calcified vessels. In vitro studies demonstrated that pooled uremic serum, compared to pooled control human serum induced the expression of Cbfa1 by RT-PCR in bovine VSMCs in a time-dependent, nonphosphorus-mediated mechanism. Conclusion. These results support that Cbfa1 is a key regulatory factor in the vascular calcification observed in dialysis patients and is up-regulated in response to many uremic toxins.

KW - Cbfa1

KW - Dialysis

KW - Osteopontin

KW - Type 1 collagen

KW - Vascular calcification

UR - http://www.scopus.com/inward/record.url?scp=0037337818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037337818&partnerID=8YFLogxK

U2 - 10.1046/j.1523-1755.2003.00820.x

DO - 10.1046/j.1523-1755.2003.00820.x

M3 - Article

C2 - 12631081

AN - SCOPUS:0037337818

VL - 63

SP - 1003

EP - 1011

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 3

ER -